Laboratorios Farmaceuticos (Spain) Top Management

ROVI Stock  EUR 52.30  0.35  0.67%   
Laboratorios Farmaceuticos employs about 1.8 K people. The company is managed by 25 executives with a total tenure of roughly 112 years, averaging almost 4.0 years of service per executive, having 70.04 employees per reported executive. Evaluation of Laboratorios Farmaceuticos' management performance can provide insight into the firm performance.
Juan Encina  CEO
Co-CEO, General Director, Executive Director
Enrique Leal  Chairman
Vice Chairman of the Board, Independent Director
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Laboratorios Farmaceuticos ROVI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Laboratorios Farmaceuticos Management Team Effectiveness

The company has return on total asset (ROA) of 0.1844 % which means that it generated a profit of $0.1844 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3919 %, meaning that it generated $0.3919 on every $100 dollars invested by stockholders. Laboratorios Farmaceuticos' management efficiency ratios could be used to measure how well Laboratorios Farmaceuticos manages its routine affairs as well as how well it operates its assets and liabilities.

Laboratorios Farmaceuticos Workforce Comparison

Laboratorios Farmaceuticos ROVI is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 38,337. Laboratorios Farmaceuticos holds roughly 1,751 in number of employees claiming about 5% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28.

Laboratorios Farmaceuticos Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Laboratorios Farmaceuticos Price Series Summation is a cross summation of Laboratorios Farmaceuticos price series and its benchmark/peer.

Laboratorios Farmaceuticos Notable Stakeholders

A Laboratorios Farmaceuticos stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Laboratorios Farmaceuticos often face trade-offs trying to please all of them. Laboratorios Farmaceuticos' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Laboratorios Farmaceuticos' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Juan EncinaCo-CEO, General Director, Executive DirectorProfile
Enrique LealVice Chairman of the Board, Independent DirectorProfile
Ivan EncinaFirst Vice Chairman of the Board, Executive Director of Corporate DevelopmentProfile
Juan LopezCo-CEO, Chairman of the Board, Executive DirectorProfile
Javier EncinaSecond Vice Chairman of the Board, Chief Financial Officer, Executive DirectorProfile
Fernando MoralesCommercial DirectorProfile
Miguel FreeseIndependent DirectorProfile
Jose MorenoBarredaIndependent DirectorProfile
Miguel SanchezIndustrial DirectorProfile
Miguel RomanDirector of International Affairs and DevelopmentProfile
Pedro TrilloDirector of Hospital NetworkProfile
Francisco GarciaDirector of Human ResourcesProfile
Ibon AdurizDirector of Preclinical ResearchProfile
Beatriz AlcaldeSales Manager Line BProfile
Ignacio ToledanoDeputy SecProfile
Gabriel FernandezNon-member SecretaryProfile
Rosario PrezMarketing MangProfile
Francisco GarcaHR MangProfile
Marcos PintoLead Independent DirectorProfile
Fernando GarijoSales Effectiveness ManagerProfile
Mercedes SanchezManager - Legal DepartmentProfile
Fatima GarciaIndependent DirectorProfile
Pablo JorgeChief Economic and Administrative OfficerProfile
M PerezMarketing ManagerProfile
Mercedes SnchezLegal MangProfile

About Laboratorios Farmaceuticos Management Performance

The success or failure of an entity such as Laboratorios Farmaceuticos often depends on how effective the management is. Laboratorios Farmaceuticos management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Laboratorios management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Laboratorios management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. LABORATORIOS FARMACEUTICOS operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1499 people.
Please note, the presentation of Laboratorios Farmaceuticos' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Laboratorios Farmaceuticos' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Laboratorios Farmaceuticos' management manipulating its earnings.

Laboratorios Farmaceuticos Workforce Analysis

Traditionally, organizations such as Laboratorios Farmaceuticos use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Laboratorios Farmaceuticos within its industry.

Laboratorios Farmaceuticos Manpower Efficiency

Return on Laboratorios Farmaceuticos Manpower

Revenue Per Employee370.5K
Revenue Per Executive25.9M
Net Income Per Employee104.3K
Net Income Per Executive7.3M

Complementary Tools for Laboratorios Stock analysis

When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal